Chief Physician, Associate Professor, Master's Supervisor, Department of Thoracic Surgery I, Peking University Cancer Hospital Professional Expertise: Comprehensive surgical treatment primarily based on surgery for malignant tumors of the thoracic surgery department. In addition to routine minimally invasive lung cancer surgery and mediastinal surgery, particularly skilled in various complex surgical treatments for esophageal cancer, such as treatment of high cervical esophageal cancer, salvage esophageal surgery after radical chemoradiotherapy, surgical management of esophageal cancer following gastric cancer surgery, and combined organ resection for esophageal cancer. Main research focus is on comprehensive treatment of locally advanced esophageal cancer. Previously studied minimally invasive thoracic tumor surgery at the Department of Thoracic Surgery, Duke Medical Center, USA, and the Department of Esophageal Surgery, National Cancer Center, Japan. Key Social Appointments: · Chinese Anti-Cancer Association: Member of the Esophageal Cancer Professional Committee, Standing Committee Member of the Esophageal Tumor Integrated Rehabilitation Committee · Chinese Medical Doctor Association: Youth Committee Member of the Thoracic Surgery Branch · Beijing Cancer Prevention and Treatment Society: Deputy Director of the Esophageal Cancer Youth Committee · Chinese Journal of Digestive Surgery Elite Group: Deputy Leader of the Esophageal Study Group · 2020 "People's Good Doctor. Jinshan Camellia Plan" Outstanding Contribution Award in Esophageal Cancer Representative Achievements: - Projects 1. Beijing Outstanding Talent Training Project (2020-2022) Multicenter randomized controlled study comparing neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy combined with minimally invasive surgery for locally advanced resectable esophageal squamous cell carcinoma 2. Beijing Municipal Health Bureau Research Ward Excellence Program (2024-2027) Randomized controlled study on real-time intraoperative neural function monitoring to reduce recurrent laryngeal nerve injury during lymph node dissection for esophageal cancer - Published Articles 1. Y. Wu, L. Dai, Y. Yang, W. Yan, H. Cheng, M. Fan, Y. Gao and K. Chen. Long-term survival and recurrence patterns in locally advanced esophageal squamous cell carcinoma patients with pathologic complete response after neoadjuvant chemotherapy followed by surgery Ann Surg Oncol. 2024;31(8):5047-5054. (IF=3.5, First Author) 2. L. Dai, Y. Wu, Y. Sun, R. Yu, W. Yan, Y. Yang, H. Cheng, Y. Gao, B. Zhang and K. Chen. Combined Chemotherapy and Immunotherapy Induction for Screening of Patients with Cervical Esophageal Carcinoma for Subsequent Local Treatment: A New Treatment Paradigm Ann Surg Oncol. 2024;31(13):9298-9309. (IF=3.5, First Author) 3. Y. Shi, S. Yan, X. Yang, Z. Guan, X. Li, L. Wang, L. Dai and Y. Sun. Early contrast-enhanced MR for diagnosing complete tumor response of locally advanced esophageal squamous cell carcinoma after neoadjuvant therapy: a retrospective comparative study Ann Surg Oncol. 2024;31(7):4271-4280. (IF=3.5, Corresponding Author) 4. B. Li, L. Dai, H. Jiang, H. Yu, Y. Chen, R. Hua, B. Li, Y. Sun, K. Chen and Z. Li. Surgical treatment of esophageal cancer with anomaly of the aortic arch and its branches Esophagus. 2021;18(3):489-495. (IF=3.671, First Author) 5. Y. Yang, L. Dai, Y. Wu, W. Yan, Z. Liang, Y. Lin and K. Chen. Pre-operative oil ingestion reduces the probability of thoracic duct trunk ligation during esophagectomy Dis Esophagus. 2023;36(6):doac093. (IF=2.4, First Author) - Teaching · Graduate Training: Independently supervised 1 master's student, co-supervised 2 doctoral students